Rodman & Renshaw analyst Ram Selvaraju weighed in on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) after the drug maker released its second-quarter results and reaffirmed its …
Rodman & Renshaw analyst Ram Selvaraju weighed in today with a few insights on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), ahead of the the upcoming Phase 3 …
In a research report released today, Rodman & Renshaw analyst Ram Selvaraju reiterated a Buy rating on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), with a …
In a research report released yesterday, Rodman & Renshaw analyst Ram Selvaraju initiated coverage on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), with a Buy rating and price …
In a research report released Wednesday, MLV & Co. analyst Ram Selvaraju initiated coverage on shares of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) with a Buy …